LERIVON 30 MG TBL FLM 20

What is the maximum co-payment for LERIVON?

If the insurance company contributes, the maximum co-payment is 72,51 Kč. The maximum pharmacy price is 133,09 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does LERIVON have a counted co-payment set?

Yes, the medicine has a counted co-payment of 38,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

60,58 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe LERIVON?

Prescription is not conditional on a medical specialization.

What is the composition of LERIVON?

Mianserin-hydrochlorid (30 mg), neznámá látka s kódem 2898, koloidní bezvodý oxid křemičitý, magnesium-stearát, methylcelulosa, dihydrát hydrogenfosforečnanu vápenatého (300 mg), hypromelosa, neznámá látka s kódem 4688, oxid titaničitý. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Documents could not be found

Which medicines are similar to LERIVON?

The medicine belongs to ATC group N06AX03 – MIANSERIN. Medicines with the same active substance can be found here.

Who manufactures LERIVON?

N.V. Organon, Oss (NL)

Is the medicine in shortage?

The latest report from the manufacturer is from 11. 5. 2022. Production was terminated with effect from 11. 5. 2022. The manufacturer lists medicines with the following code as a potential substitute: